salicylic acid has been researched along with dacarbazine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Babu, NJ; Nangia, A; Sanphui, P | 1 |
Carey, RW; Kunz, VS | 1 |
Calista, D; Landi, C; Schianchi, S | 1 |
Binder, B; Cerroni, L; Kerl, H; Richtig, E; Smolle, J; Wolf, IH | 1 |
Sarma, N | 1 |
Berking, C; Flaig, MJ; Kunte, C; Roider, E; Ruzicka, T; Schneider, J | 1 |
Abasq, C; Charles-Pétillon, F; Coat, C; De Braekeleer, M; Marcorelles, P; Quintin-Roué, I; Talagas, M; Uguen, A | 1 |
8 other study(ies) available for salicylic acid and dacarbazine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Crystal engineering of stable temozolomide cocrystals.
Topics: Antineoplastic Agents, Alkylating; Crystallization; Crystallography, X-Ray; Dacarbazine; Drug Stability; Half-Life; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrolysis; Malates; Molecular Conformation; Oxalic Acid; Salicylic Acid; Succinic Acid; Tartrates; Temozolomide; Temperature | 2012 |
Acute non-lymphocytic leukemia (ANLL) following treatment with dacarbazine for malignant melanoma.
Topics: Acute Disease; Dacarbazine; Humans; Leukemia; Male; Melanoma; Middle Aged; Muramidase; Scalp; Skin Neoplasms | 1987 |
Malignant blue nevus of the scalp.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Fatal Outcome; Humans; Interferon-alpha; Liver Neoplasms; Lung Neoplasms; Nevus, Blue; Scalp; Skin Neoplasms; Vindesine | 1998 |
Topical imiquimod in the treatment of metastatic melanoma to skin.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dacarbazine; Female; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Knee; Leg; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Scalp; Skin Neoplasms; Treatment Outcome | 2003 |
Stevens-Johnson Syndrome and toxic epidermal necrolysis overlap due to oral temozolomide and cranial radiotherapy.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Glioblastoma; Humans; Male; Middle Aged; Neck; Radiotherapy; Scalp; Stevens-Johnson Syndrome; Temozolomide; Thorax | 2009 |
Hypopigmentation in the sites of regressed melanoma metastases after successful dacarbazine therapy.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Forearm; Head and Neck Neoplasms; Humans; Hyperpigmentation; Male; Melanoma; Middle Aged; Scalp; Skin Neoplasms; Torso | 2012 |
[A silent-growing and fast-killing melanoma in a teenager].
Topics: Adolescent; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Back Pain; Combined Modality Therapy; Cyclin D1; Dacarbazine; Drug Resistance, Neoplasm; Fatal Outcome; Female; Gene Amplification; Head and Neck Neoplasms; Humans; Immunotherapy; In Situ Hybridization, Fluorescence; Ipilimumab; Lymphatic Metastasis; Melanoma; Nausea; Neoplasm Proteins; Neoplasms, Second Primary; Nevus; Osteolysis; Scalp; Skin Neoplasms; Weight Loss | 2012 |